3 H-NEFA release, indicating increased NEFA trapping in WAT. Conversely, in muscle, ASP induced effects opposite to those in WAT and increased lipolysis, indicating reduced NEFA trapping within muscle by ASP (P Ͻ 0.05 for all parameters). In conclusion, novel data in this study suggest that 1) there is little intrinsic difference between KO and WT tissue in the parameters examined and 2) ASP differentially regulates in situ LPL activity and NEFA trapping in WAT and skeletal muscle, which may promote optimal insulin sensitivity in vivo. acylation-stimulating protein; C3adesArg; fatty acid; triglyceride; lipoprotein lipase; brown adipose tissue FAT STORAGE OR FATTY ACID TRAPPING in white adipose tissue (WAT) is determined by the equilibrium of two reciprocal metabolic processes, triglyceride (TG) synthesis and lipolysis. Acylation-stimulating protein (ASP; aka C3adesArg) is a WAT-derived hormone (36) that markedly affects the reciprocal rates of both TG synthesis and lipolysis. ASP enhances TG synthesis in a concentration-and time-dependent manner in a number of cell models, including human preadipocytes and adipocytes and murine 3T3-L1 preadipocytes (3, 25, 36, 64) . This effect is mediated by two mechanisms. First, ASP stimulates the activity of diacylglycerol acyltransferase, the last enzyme involved in TG synthesis and believed to be the rate-limiting step and, hence, indirectly increases nonesterified fatty acid (NEFA) uptake and esterification (68). Second, ASP directly increases glucose uptake and transport in cultured human skin fibroblasts (25), human adipocytes (36), and rat muscle cells (62). On the other hand, a study in human adipocytes demonstrated that ASP also decreases lipolysis and increases fractional reesterification of NEFA (63). The effects of ASP are likely mediated by a recently identified receptor, C5L2 (aka gpcr 77), that is expressed in human WAT, 3T3-L1 preadipocytes, and human skin fibroblasts, cell models that are responsive to ASP action (30).
FAT STORAGE OR FATTY ACID TRAPPING in white adipose tissue (WAT) is determined by the equilibrium of two reciprocal metabolic processes, triglyceride (TG) synthesis and lipolysis. Acylation-stimulating protein (ASP; aka C3adesArg) is a WAT-derived hormone (36) that markedly affects the reciprocal rates of both TG synthesis and lipolysis. ASP enhances TG synthesis in a concentration-and time-dependent manner in a number of cell models, including human preadipocytes and adipocytes and murine 3T3-L1 preadipocytes (3, 25, 36, 64) . This effect is mediated by two mechanisms. First, ASP stimulates the activity of diacylglycerol acyltransferase, the last enzyme involved in TG synthesis and believed to be the rate-limiting step and, hence, indirectly increases nonesterified fatty acid (NEFA) uptake and esterification (68) . Second, ASP directly increases glucose uptake and transport in cultured human skin fibroblasts (25) , human adipocytes (36) , and rat muscle cells (62) . On the other hand, a study in human adipocytes demonstrated that ASP also decreases lipolysis and increases fractional reesterification of NEFA (63) . The effects of ASP are likely mediated by a recently identified receptor, C5L2 (aka gpcr 77), that is expressed in human WAT, 3T3-L1 preadipocytes, and human skin fibroblasts, cell models that are responsive to ASP action (30) .
C3 knockout (KO) mice are necessarily ASP deficient and manifest many metabolic aberrations indicative of subnormal fat storage. With an acute oral fat challenge, male KO (C3 Ϫ/Ϫ ) 129sv-backcrossed mice demonstrate a distinct delay in TG and NEFA clearance, whereas female KO mice (C3 Ϫ/Ϫ ) or C57Bl/6 mice (C3 Ϫ/Ϫ ) do not (15, 42, 43) . Acute administration of ASP by intraperitoneal injection enhances postprandial TG clearance not only in male KO mice (42) but also in WT C57Bl/6 mice (41) and two obese mice models examined (ob/ob and db/db) (54) . In contrast, the long-term effect of ASP deficiency on fat storage is evident in altered body composition in all KO mice examined (regardless of sex or genotype). Female KO mice have reduced body weight and WAT mass, lower leptin concentration, and higher insulin sensitivity (15, 40) . Male KO mice also have reduced WAT mass, lower glucose and leptin concentrations, and higher insulin sensitivity (15, 43) . Both male and female KO mice have decreased feed efficiency compared with WT mice, which results in less body weight gain for greater food intake (40, 43) .
In a double-KO model that is ASP and leptin deficient (ob/ob, C3 Ϫ/Ϫ ), both male and female mice have delayed postprandial TG and NEFA clearance compared with ob/ob mice, despite higher insulin sensitivity, and they have reduced body weight despite greater food intake (66) . Decreased body weight in double-KO mice in the face of hyperphagia is counterbalanced by increased energy expenditure in these mice (66) .
Taken together, these findings indicate that ASP deficiency leads to significant alterations in carbohydrate and lipid metabolism that result in deficient TG clearance and storage in WAT. The clearance of postprandial lipemia, however, involves the activity of endothelial lipoprotein lipase (LPL). LPL hydrolyzes TG-rich lipoproteins and releases NEFA, which are taken up and used by underlying tissue for their specific metabolic needs (for review see Ref. 38 ). The major physiological sites for postprandial LPL regulation are WAT and skeletal muscle (13) . In WAT, NEFA are mainly esterified and stored as TG. In working skeletal muscle, although NEFA may temporarily enter the TG pool, they are mainly routed toward oxidation to accommodate the energy needs of the muscle and other tissues (38) . In vivo in the postprandial period, LPL activity is upregulated in WAT and downregulated in muscle, and the reverse is true in the fasting period (11, 23, 49) . This reciprocal regulation of LPL activity in WAT and muscle is believed to be mediated by reciprocal effects of insulin (11, 49) . Male KO mice have delayed postprandial TG clearance despite higher insulin sensitivity. This, we hypothesize, is secondary to ASP deficiency in these mice that results in defective hydrolysis of TG-rich lipoproteins and reduced esterification and storage of the generated NEFA. Thus the overall objective of the present work was to investigate the mechanism by which ASP deficiency leads to subnormal postprandial TG clearance and fat storage ex vivo in male KO mice. 1 Ci/ml) were from PerkinElmer (PerkinElmer Life Sciences, Boston, MA). Triolein, oleate, egg yolk L-␣-phosphatidylcholine, and bovine milk LPL were from Sigma (Sigma-Aldrich Canada, Oakville, ON, Canada). ␣-Methylbenzylamine, 99% (CO 2 trapping agent), was from Aldrich (Milwaukee, WI). Fatty acid-free bovine serum albumin (BSA) was obtained from ICN Biomedical (Aurora, OH). Calcium-free Krebs-Ringer buffer (KR buffer), pH 7.2, contained (in mM) 5 glucose, 0.51 MgCl 2, 4.56 KCl, 119.8 NaCl, 0.7 Na2HPO4 1.3 NaH2PO4, and 15.0 NaHCO3, and 1% fatty acid-free BSA. ASP was prepared by an in-house purification method from fasting human plasma, as previously described (37, 55) . Tissue culture plates were from Falcon (Becton Dickinson, Franklin Lakes, NJ). Thin-layer chromatography plates (TLC plates LK5 silica gel 150 A) were from Whatman (Clifton, NJ).
MATERIALS AND METHODS

Materials
Animals. Experiments were conducted on six wild-type (WT) and six ASP-deficient (C3 Ϫ/Ϫ ) male mice (14 -15 wk old). Complement C3 KO (C3 Ϫ/Ϫ ) mice (on 129sv ϫ C57Bl/6 strain), as well as WT mice, were originally obtained from Dr. Harvey Colton [Dept. of Pediatrics, Washington U., St. Louis, Missouri (42, 43) ]. Mice were backcrossed 8 -10 generations to obtain a homogenous 129sv genetic background (15) . Mice were housed in a pathogen-free barrier facility at 21°C on a 12:12-h dark-light cycle and provided with water and standard chow ad libitum. All procedures on mice followed the guidelines established by the Canadian Animal Care Center and were approved by the McGill University Health Centre Animal Care Committee. The mice were selected by genotyping with PCR as described previously for C3, using tail tips collected when the mice were weaned at 3 wk of age (40, 43) .
Tissue extraction. On the day of the experiment, one pair of WT and KO male mice (fasted for 16 h) was killed by cervical dislocation. Epididymal WAT, vastus lateralis muscles, BAT, and liver were isolated and maintained in ice-cold KR buffer until all tissues were extracted. Tissues were cut into small pieces (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) 3 H-NEFA released into the medium. The percent chase/pulse for 3 H-and 14 C-labeled tissue lipids was calculated as 3 H label in chase/ 3 H label in pulse ϫ 100 in each measured lipid fraction (total lipids, TG, DG ϩ MG, and NEFA).
Measurement of substrate oxidation and lipolysis. The complete oxidation of 3 H-NEFA was assayed by measuring 3 H2O release into the incubation medium with modification of the method described by Lee et al. (34) . The medium was precipitated twice with 60% trichloroacetic acid (final concentration 10%) to remove excess [ 3 H]oleate-BSA. The supernatant was transferred into 1.5-ml microcentrifuge tubes (with caps cut off), which were placed in 16-ml scintillation vials to which 2 ml of unlabeled distilled water had been previously added. The scintillation vials were capped tightly, wrapped individually with foil, and incubated in an oven (55°C) for 18 h to allow equilibrium of 3 H2O vapor in the microcentrifuge tubes with unla-beled H2O vapor in the scintillation vials. Counts in H2O in the scintillation vials were measured. To determine 3 H2O equilibrium coefficient, 250 l of 3 H2O standard (in KR buffer) were analyzed in parallel with the experimental samples, and data were corrected accordingly. On average, 72.1 Ϯ 2.2% of 3 H2O standard counts in the microcentrifuge tubes were recovered in the water in the scintillation vials.
The complete aerobic oxidation of [ 14 C]glucose was assayed by measuring 14 CO2 dissolved in the incubation medium by a modification of the technique used by Muoio et al. (39) . Medium (250 l) was transferred to a 12 ϫ 75-mm glass test tube, and a piece of saturation pad (1.1 ϫ 2.5 cm 2 ) with 150 l of methylbenzylamine (CO2 trapping agent) was fixed vertically between the inner walls of the tube. Test tubes were stoppered, 100 l of 70% perchloric acid were injected into each tube (not touching the saturation pads), and tubes were incubated overnight at 37°C in a shaking water bath to release 14 CO2. Saturation pad pieces with trapped 14 CO2 were collected and dropped into 10 ml of scintillation fluid and counted.
In the chase period, lipolysis in WAT and muscle was assessed by the release of glycerol into the medium (12, 63) by use of a modification of a commercial kit by Xygen (Xygen Diagnostic, Burgessville, ON, Canada). Sensitivity of the assay was increased whereby samples in the range of 16.6 -333.3 nmol glycerol/ml could be measured. Total NEFA mass released into the medium was measured by a commercial kit (Wako Chemicals, Richmond, VA).
3 H-NEFA release was measured by extraction of the medium with chloroform-methanol (2:1) as described above. [ 3 H]oleate standard (in KR buffer) was analyzed in parallel with the experimental samples, and data were corrected accordingly. On average, 75.0 Ϯ 3.8% of [ 3 H]oleate standard counts were recovered in the organic phase.
Statistical analyses. Experiments were conducted on tissue pieces collected from all 12 mice with two pieces per tissue per mouse for WAT, muscle, and liver and one piece per mouse for BAT. Data are presented as averages Ϯ SE. Statistical significance was determined by paired t-test for within-group differences (within KO or WT) or by unpaired t-test for between-group differences (KO vs. WT), and significance was set at P Ͻ 0.05 and power of Ն80%. In situ LPL activity in the presence of ASP was comparable between WT and KO in both WAT and muscle, suggesting that the difference between WT and KO mice is a consequence of the absence of ASP, not an intrinsic difference in the tissue lipid metabolism. Consequently, data were pooled for all mice (KO ϩ WT), as presented in Fig. 1 Fig. 1 vs. Fig. 2 Ϫ/Ϫ knockout (KO) mice (n ϭ 6), *P Ͻ 0.05 and **P Ͻ 0.001 for ASP effect vs. baseline.
RESULTS
Effect of ASP on in situ LPL
Fig. 2. Substrate oxidation and incorporation into lipids in WT vs. ASP-deficient C3
Ϫ/Ϫ KO mice in WAT, brown adipose tissue (BAT), muscle, and liver (pulse period). Tissue pieces of WT (n ϭ 6) and ASP-deficient C3 Ϫ/Ϫ KO mice (n ϭ 6) were incubated for 90 min with (22, 52) and [ 14 C]glycerol can be reused to synthesize TG, it is hard to distinguish whether the increased radiolabeled lipids in BAT of KO mice are due to increased 3 H-NEFA reesterification, reduced lipolysis, or both.
The percent changes in the fate of incorporated labels by ASP in WAT, BAT, muscle, and liver are shown in Fig. 3 , C and D. Because there was no difference between KO or WT mice in their response to ASP in any outcome measured or tissue examined, even BAT (data not shown), data were pooled. As with the previous observation on in situ LPL activity, ASP had opposing effects on radiolabeled lipid storage in WAT and skeletal muscle in the chase period. In WAT, ASP significantly increased the amount of retained 14 C-and 3 H-lipids (P Ͻ 0.05) and decreased by an equivalent amount the 3 H-NEFA released into the medium (P ϭ 0.02). Total NEFA mass released from WAT was also decreased with ASP incubation by 23% (baseline: 3.47 Ϯ 0.29 vs. ASP: 2.64 Ϯ 0.16 nmol NEFA/mg WAT, P ϭ 0.02). Lipolysis could not be assessed in WAT because glycerol release was below the sensitivity range of the assay (Ͻ16.6 nmol glycerol/ml).
The effect of ASP on the redistribution of prelabeled 3 Hlipid fractions (total 3 H-lipids, [ 3 H]TG, [ 3 H]DG ϩ MG, and 3 H-NEFA) during the 2-h chase period is presented as %chase/ pulse (Fig. 4) 3 H-NEFA onto prelabeled DG and MG precursors and onto unlabeled glycerol backbone supplied as glucose in the medium. Thus, taken together, these data suggest that, in WAT, 1) there is no effect of ASP on lipolysis or on reesterification of 3 H-NEFA onto [ 14 C]DG ϩ MG, as the %chase/pulse in [ 14 C]TG was not affected, and 2) the net effect of ASP is to increase the TG synthesis-to-lipolysis ratio favoring reesterification of 3 H-NEFA onto an unlabeled glycerol backbone.
As shown in Fig. 3 , C and D, in contrast to the effect in WAT, ASP decreased the amount of retained 14 C-and 3 Hlipids in muscle (P ϭ 0.04) without, however, increasing 3 H-NEFA release into the medium. Moreover, in the muscle, as seen in Fig. 4 , ASP decreased the %chase/pulse of [ 14 C-labeled lipids remaining in the chase period. A and B: *P Ͻ 0.05 and **P Ͻ 0.01 for WT (n ϭ 6) vs. KO (n ϭ 6). C and D: data are pooled for WT (n ϭ 6) and KO mice (n ϭ 6). *P Ͻ 0.05 and **P Ͻ 0.001 for %change with ASP effect vs. baseline. 
DISCUSSION
WAT provides a "buffering" system for the acute increase in NEFA influx derived from the hydrolysis of dietary TG-rich lipoprotein. "NEFA trapping" in WAT as stored TG prevents NEFA circulation at high concentration and efflux to other peripheral tissue beyond the metabolic need of these tissues to assimilate NEFA. Excess NEFA influx to muscle and liver is associated with lipotoxicity and insulin resistance in mice and human models (9, 10, 31, 32, 47, 60) . ASP-deficient C3 Ϫ/Ϫ mice have reduced capacity for TG synthesis in WAT and elevated postprandial NEFA concentration, yet they have enhanced whole body insulin sensitivity, as indicated by lower plasma glucose and insulin concentrations at fasting and after glucose tolerance test (42) . These mice, however, have elevated energy expenditure, as shown in both double-KO (C3 Ϫ/Ϫ ob/ob) (66) and single-KO (C3 Ϫ/Ϫ 129sv) ASP-deficient mice (67) . Thus, despite delayed postprandial TG and NEFA clearance, these mice are protected against the detrimental effects of increased postprandial NEFA influx by upregulating oxidation and energy expenditure (67) . It was, however, unknown whether this alteration in energy metabolism in C3 Ϫ/Ϫ mice in vivo was a direct or indirect effect of ASP deficiency. To identify the specific mechanism by which ASP deficiency leads to subnormal postprandial TG clearance and fat storage in male KO mice, we examined substrate (glucose and oleate) metabolism ex vivo in the presence and absence of ASP in tissues that are most active in this process.
Under these experimental conditions, our data suggest that there are no intrinsic tissue differences between KO and WT mice in in situ LPL activity, substrate oxidation, TG synthesis, lipolysis, and reesterification in all tissues examined except BAT. In BAT of KO mice, TG storage was enhanced. This finding may explain previous data indicating increased BAT mass in male KO mice (42) and suggests that, in vivo, increased BAT mass in KO mice is not secondary to rechanneling of NEFA from WAT to BAT but to an intrinsic tissue resistance to baseline lipolysis. ASP-deficient KO mice have increased energy expenditure even in the sleeping period (67) . Thus, in vivo, increased TG storage in BAT in KO mice may be a mechanism to ensure a larger in situ reservoir for NEFA oxidation, particularly when external energy supply is diminished during fasting. Future studies examining thermogenesis and the activity of uncoupling protein ex vivo in BAT in the absence and presence of ASP could verify this hypothesis.
An interesting observation in this study is that the delivery route of 3 H-fatty acid had an impact on utilization. The uptake and storage of albumin-bound 3 H-NEFA was much smaller than TG-derived 3 H-NEFA in both KO and WT mice. This may be due to differences in the mechanism of their uptake into the tissue. Transport of LPL-derived NEFA into TG-synthesizing tissue (adipose tissue, liver, heart, and skeletal muscle) is suggested to be via lateral movement through a continuum interface from the TG-rich lipoproteins' surface phospholipid film into the cellular membranes of the parenchymal cell (7, (57) (58) (59) . On the other hand, it is proposed that albumin-bound NEFA are transported either actively via membrane transporters (1, 2, 6, 56) or passively through a "flip-flop" mechanism that is driven by a concentration gradient across the plasma membrane (28) . In fact, it has been previously suggested that, depending on the mode of uptake, TG-derived NEFA and albumin-bound NEFA do not enter the same metabolic pool in the tissue (35) . In a recent study on perfused mouse heart, the proportion of oxidized to stored NEFA was increased when chylomicron infusion was substituted for NEFA infusion (35) .
Although there were no intrinsic tissue differences in substrate metabolism in WAT and muscle between WT and KO mice, novel data from the present study suggest that ASP has differential effects on NEFA trapping in these tissues, as represented schematically in Fig. 6 . In WAT, ASP increases in situ LPL activity, hydrolysis of [ 3 H]triolein substrate, and trapping of generated 3 H-fatty acid in the form of TG, whereas decreased NEFA release from the tissue (Fig. 6A) . Conversely, in muscle, ASP decreased in situ LPL activity, hydrolysis of [ 3 H]triolein substrate and trapping of generated 3 H-fatty acid, whereas it increased lipolysis (Fig. 6B) .
This differential regulation of LPL activity in WAT and muscle is observed in vivo in the fasting and fed states. Several lines of evidence suggest that LPL activity is under nutritional regulation, increasing in WAT and decreasing in muscle with the postprandial rise in insulin, and reciprocal changes are observed during fasting (11, 23, 48) . In rats, postprandial heparin-releasable LPL activity increases by 65% above fasting values in epididymal and retroperitoneal WAT while decreasing by 25% in soleus muscle 1 h after the ingestion of a high-carbohydrate meal (49) . This effect is partially diminished by inhibition of insulin secretion from the pancreas (49) or reduction of postprandial insulinemia by Intralipid injection and high-fat meal feeding (19, 20) . Endothelial LPL in WAT is the key enzyme responsible for TG clearance (38) . In addition, postprandial TG concentration has been suggested to be more closely regulated by the rate of TG clearance than the rate of hepatic TG secretion (16 -18, 50) . Thus reduced in situ LPL activity in WAT with ASP deficiency may contribute to delayed postprandial TG and NEFA clearance in male KO mice and may explain the normalization of TG clearance when ASP is administered. It is important to point out, however, that, compared with WT mice, male KO mice have enhanced insulin sensitivity, as indicated by a decreased insulin response after a glucose tolerance test (43) . Yet, despite enhanced insulin sensitivity in KO mice, which might be expected to enhance WAT LPL activity, delayed postprandial TG and NEFA clearance is characteristic of these mice (43) . This suggests that insulin action is not the sole regulator of postprandial LPL activity and TG clearance. Insulin-mediated upregulation of postprandial LPL activity in WAT may be overwhelmed by the effects of ASP deficiency on LPL activity and WAT lipogenesis, resulting in delayed TG clearance in KO mice.
Despite the well-documented regulation of LPL activity by insulin and nutritional interventions, the mechanism by which insulin elucidates its tissue-specific effects on LPL activity, particularly in muscle, is poorly understood. In WAT, it is suggested that the short-term effect of feeding and insulin on LPL activity is mediated by posttranslational modulation that includes increased LPL activation, increased active LPL release, and decreased LPL degradation (4, 14, 65) . More recently, it was proposed that, during fasting, a gene is activated that downregulates LPL activation without affecting LPL synthesis (5) . Recent in vitro data from our laboratory demon- strated that both ASP and insulin increase in situ LPL activity in 3T3-L1 adipocytes, as measured by increasing synthetic [ 3 H]TG-rich lipoprotein hydrolysis and 3 H-NEFA incorporation into the adipocytes (21) . ASP stimulates this effect on synthetic [ 3 H]TG-rich lipoprotein hydrolysis by stimulating TG synthesis in adipocytes and, hence, by removal of NEFA inhibition of LPL, despite the lack of any direct stimulatory effect of ASP on heparin-releasable LPL activity (as opposed to the stimulatory effect of insulin on heparin-releasable LPL activity) (21) . In the present work, a similar mechanism may be employed in WAT and a reciprocal one in skeletal muscle. In the muscle, increased endogenous TG lipolysis and decreased lipogenesis by ASP may exert a feedback inhibition on in situ LPL activity. The tissue-specific mechanism and signal transduction pathways by which ASP regulates the balance between lipolysis and lipogenesis in skeletal muscle are yet to be examined.
The decrease in muscle TG synthesis by ASP may have specific long-term metabolic consequences. Increased intramyocyte TG content is associated with concurrent onset of insulin resistance in many human and mouse studies (9, 31, 47) . Mice overexpressing muscle LPL have a threefold increase in muscle TG and are insulin resistant (51) . The metabolic abnormalities associated with increased muscle TG are proposed to be secondary to increased metabolites long-chain acyl-CoA and diacylglycerol, which inhibit glycolytic enzymes and glucose utilization and interfere with insulin signaling and insulin-mediated glucose uptake (51) . Pioglitazone (an enhancer of insulin action) administration to insulin-resistant hypertriglyceridemic mice increases LPL production in WAT but not in skeletal muscle (29) . It was concluded that this differential tissue effect of the drug may help prevent the development of muscle lipotoxicity and insulin resistance in these mice (29) . Thus, in vivo, the reciprocal regulation of NEFA trapping in WAT and muscle by ASP, in addition to insulin, may be a mechanism to target NEFA accumulation in the physiological depot. This would help ensure the maintenance of optimal insulin sensitivity.
It should be pointed out, however, that this is not in disagreement with our previous in vivo findings that ASP-deficient mice have increased whole body insulin sensitivity (40, 43, 66) . In vivo, ASP deficiency leads to reduced WAT mass, and the tight correlation of insulin sensitivity and body weight is likely to explain the increased insulin sensitivity in KO mice. In addition, ASP-deficient mice have increased energy expenditure, which would channel NEFA to oxidation, prevent the exposure of nonadipose tissues to long-term NEFA efflux and the accumulation of muscle and liver TG. This may thus mask the effect of ASP deficiency and defective NEFA trapping in WAT on insulin resistance. Confirming this, fasting plasma NEFA and TG levels are normal in C3 Ϫ/Ϫ KO mice, even on a high-fat diet (43) . Plasma TG and NEFA are elevated in these mice only in the postprandial period following a fat load (43), i.e., when the effect of defective WAT NEFA trapping is more readily perceived with a sudden high influx of dietary fat.
However, a defective ASP pathway may exacerbate the development or maintenance of insulin resistance when increased total body NEFA input is not counterbalanced by increased NEFA disposal, i.e, in positive energy balance and obesity models. Although the defects underlying the etiology of abnormal lipid metabolism and insulin resistance in obese subjects are unknown, it is generally accepted that elevated plasma NEFA concentrations play a major role (8) . A number of studies show that the balance between insulin-stimulated intracellular lipolysis and lipogenesis is defective in obese individuals, with a shift toward increased net NEFA efflux from WAT (18, 24, 27) . In addition, it was demonstrated that the habitual insulin-mediated rise in WAT LPL activity in the postprandial period is defective in obese and type 2 diabetic humans, which is suggested to exacerbate postprandial hypertriglyceridemia (18, 44, 46, 53) . Increased circulating NEFA, fasting and postprandial TG, and decreased NEFA oxidation in muscle are factors proposed to increase muscle lipotoxicity and insulin resistance (33) . However, although obesity is clearly a risk factor for diabetes, many obese individuals never develop any abnormal metabolic profile; in fact only ϳ15-20% of obese subjects ultimately become diabetic (9) . Thus a defective ASP pathway may contribute to the development of the metabolic abnormalities and insulin resistance associated with some types of obesity through delayed postprandial TG clearance, inefficient NEFA trapping in WAT, and elevated NEFA influx and storage in skeletal muscle.
